~~<i id='E9D628BCE2'><strike id='E9D628BCE2'><tt id='E9D628BCE2'><pre id='E9D628BCE2'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

fashion

author：entertainment 2025-09-06 03:50:44 - browse：53762

The Roche booth at ESMO in Madrid. — Roche's booth at the 2023 ESMO conference. Andrew Joseph/STAT

MADRID — A Roche drug lowered the risk of recurrence or death by 76% versus chemotherapy for patients with a type of early non-small cell lung cancer, according to data from a Phase 3 trial presented Saturday.

The findings, which Roche is planning to submit to regulators, could give patients with early-stage ALK-positive cancers another option. The standard treatment after surgery for these patients is chemotherapy.

The results from the Alina trial were presented here at the annual meeting of the European Society for Medical Oncology.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： New weight loss drugs vying to be the next Wegovy or Mounjaro

focus

hotspot

entertainment

Wikipedia

MollyFergusonforSTATTheexplodingpopularityofdrugslikeWegovyandMounjarohaspropelleddozensofcompaniest

WSS

Where does female orgasm come from? Scientists think they know

What Henrietta Lacks's story taught me about my role as a doctor

How housing is health care on Long Island

Generate Biomedicines machine learning biotech raises $273M

Long Covid needs a new name — and a new frame

Acelyrin, a rare IPO success, stumbles in its first big test

hotspot

fashion

focus

As demand for Covid shots wanes, Moderna seeks its next success

How medical schools plan to diversify without affirmative action

Peter Hotez and the public health issue of online harassment

FDA approves first blood sugar monitor without finger pricks

Alkermes shareholders re

Food makers tried to stack nutrition panel with preferred experts

Activists slam private health insurers over coverage restrictions

Pig kidney works a record two months in donated body

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Popular nasal decongestant doesn't actually relieve congestion

focus

Food makers to regulators: Ultra

Burning questions about Delta and the next phase of the Covid pandemic

What Henrietta Lacks's story taught me about my role as a doctor

Telehealth for opioid use disorder is lifesaving

PEPFAR is under serious threat — and so is global health

Long Covid needs a new name — and a new frame

focus

hotspot

entertainment

Wikipedia